§1074f. Medical tracking system for members deployed overseas
(a)
(b)
(i) accurately record the health status of members before their deployment;
(ii) accurately record any changes in their health status during the course of their deployment; and
(iii) identify health concerns, including mental health concerns, that may become manifest several months following their deployment.
(B) The postdeployment medical examination shall be conducted when the member is redeployed or otherwise leaves an area in which the system is in operation (or as soon as possible thereafter).
(C) The postdeployment health reassessment shall be conducted at an appropriate time during the period beginning 90 days after the member is redeployed and ending 180 days after the member is redeployed.
(2) The predeployment medical examination, postdeployment medical examination, and postdeployment health reassessment of a member of the armed forces required under paragraph (1) shall include the following:
(A) An assessment of the current treatment of the member and any use of psychotropic medications by the member for a mental health condition or disorder.
(B) An assessment of traumatic brain injury.
(C) An assessment of post-traumatic stress disorder.
(3)(A) The Secretary shall establish for purposes of subparagraphs (B) and (C) of paragraph (2) a protocol for the predeployment assessment and documentation of the cognitive (including memory) functioning of a member who is deployed outside the United States in order to facilitate the assessment of the postdeployment cognitive (including memory) functioning of the member.
(B) The protocol under subparagraph (A) shall include appropriate mechanisms to permit the differential diagnosis of traumatic brain injury in members returning from deployment in a combat zone.
(c)
(d)
(2) The quality assurance program established under paragraph (1) shall also include the following elements:
(A) The types of healthcare providers conducting postdeployment health assessments and reassessments.
(B) The training received by such providers applicable to the conduct of such assessments and reassessments, including training on assessments and referrals relating to mental health.
(C) The guidance available to such providers on how to apply the clinical practice guidelines developed under subsection (e)(1) in determining whether to make a referral for further evaluation of a member of the armed forces relating to mental health.
(D) The effectiveness of the tracking mechanisms required under this section in ensuring that members who receive referrals for further evaluations relating to mental health receive such evaluations and obtain such care and services as are warranted.
(E) Programs established for monitoring the mental health of each member who, after deployment to a combat operation or contingency operations, is known-
(i) to have a mental health condition or disorder; or
(ii) to be receiving treatment, including psychotropic medications, for a mental health condition or disorder.
(F) The diagnosis and treatment of traumatic brain injury and post-traumatic stress disorder.
(e)
(1) development of clinical practice guidelines to be utilized by healthcare providers in determining whether to refer a member of the armed forces for further evaluation relating to mental health (including traumatic brain injury);
(2) mechanisms to ensure that healthcare providers are trained in the application of such clinical practice guidelines; and
(3) mechanisms for oversight to ensure that healthcare providers apply such guidelines consistently.
(f)
(2) The standards required by paragraph (1) shall include the following:
(A) A specification of the mental health conditions, treatment for such conditions, and receipt of psychotropic medications for such conditions that preclude deployment of a member of the armed forces to a combat operation or contingency operation, or to a specified type of such operation.
(B) Guidelines for the deployability and treatment of members of the armed forces diagnosed with a severe mental illness, traumatic brain injury, or post traumatic stress disorder.
(3) The Secretary shall take appropriate actions to ensure the utilization of the standards prescribed under paragraph (1) in the making of determinations regarding the deployability of members of the armed forces to a combat operation or contingency operation.
(Added
Amendments
2011-Subsec. (b)(1).
Subsec. (b)(2).
Subsec. (c).
Subsec. (d)(1).
Subsec. (d)(2)(A).
Subsec. (d)(2)(B).
2009-Subsec. (f)(3).
2008-Subsec. (b)(2)(C).
Subsec. (b)(3).
Subsec. (d)(2)(F).
Subsec. (f).
Subsec. (f)(2)(B).
2006-Subsec. (b).
Subsec. (d).
Subsec. (e).
Subsec. (f).
Sharing Between Department of Defense and Department of Veterans Affairs of Records and Information Retained Under the Medical Tracking System for Members of the Armed Forces Deployed Overseas
"(a)
"(b)
Comprehensive Policy on Consistent Neurological Cognitive Assessments of Members of the Armed Forces Before and After Deployment
"(a)
"(b)
Mental Health Assessments for Members of the Armed Forces Deployed in Connection With a Contingency Operation
Administration and Prescription of Psychotropic Medications for Members of the Armed Forces Before and During Deployment
"(a)
"(b)
"(1) The circumstances or diagnosed conditions for which such medications may be administered or prescribed.
"(2) The medical personnel who may administer or prescribe such medications.
"(3) The method in which the administration or prescription of such medications will be documented in the medical records of members of the Armed Forces.
"(4) The exam, treatment, or other care that is required following the administration or prescription of such medications."
Pilot Projects
"(A) In developing the protocol required by paragraph (3) of section 1074f(b) of title 10, United States Code (as amended by paragraph (1) of this subsection), for purposes of assessments for traumatic brain injury, the Secretary of Defense shall conduct up to three pilot projects to evaluate various mechanisms for use in the protocol for such purposes. One of the mechanisms to be so evaluated shall be a computer-based assessment tool which shall, at a minimum, include the following:
"(i) Administration of computer-based neurocognitive assessment.
"(ii) Pre-deployment assessments to establish a neurocognitive baseline for members of the Armed Forces for future treatment.
"(B) Not later than 60 days after the completion of the pilot projects conducted under this paragraph, the Secretary shall submit to the appropriate committees of Congress [Committees on Armed Services, Veterans' Affairs, and Appropriations of the Senate and the House of Representatives] a report on the pilot projects. The report shall include-
"(i) a description of the pilot projects so conducted;
"(ii) an assessment of the results of each such pilot project; and
"(iii) a description of any mechanisms evaluated under each such pilot project that will be incorporated into the protocol.
"(C) Not later than 180 days after completion of the pilot projects conducted under this paragraph, the Secretary shall establish a means for implementing any mechanism evaluated under such a pilot project that is selected for incorporation in the protocol."
Implementation
Interim Standards for Blood Sampling
"(1)
"(A) the blood samples necessary for the predeployment medical examination of a member of the Armed Forces required under section 1074f(b) of title 10, United States Code, be drawn not earlier than 120 days before the date of the deployment; and
"(B) the blood samples necessary for the postdeployment medical examination of a member of the Armed Forces required under such section 1074f(b) of such title be drawn not later than 30 days after the date on which the deployment ends.
"(2)